Weight-Based Standardized Sugammadex Dosing in Pediatrics: A Quality Improvement Initiative to Improve Compliance with Dosing Guidelines and Reduce Waste and Cost
Study Objective. Sugammadex is a widely used neuromuscular blockade reversal agent. Cost concerns limit use in pediatric patients for, whom recommended doses are often far less than vial quantities. Therefore, we undertook a quality improvement initiative at a pediatric hospital in which sugammadex...
Saved in:
Main Authors: | Sydney E. S. Brown, Michael Meyer, Andrea Meyer, Ruth Cassidy, Xinyi Zhao, Deborah Wagner, Laura Wetzel, Douglas A. Colquhoun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Anesthesiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2024/6049114 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients
by: Ji-Yoon Jung, et al.
Published: (2025-01-01) -
Effect of Different Doses of Sugammadex on Recovery and Hemodynamic Parameters in Reversing Neuromuscular Blockade in Patients Undergoing Electroconvulsive Therapy
by: Kadir ARSLAN, et al.
Published: (2024-03-01) -
Improved Outcome of Biliary Atresia with Postoperative High-Dose Steroid
by: Rui Dong, et al.
Published: (2013-01-01) -
Impact of Quality Improvement Bundle on Compliance with Resuscitation Guidelines during In-Hospital Cardiac Arrest in Children
by: Pranali Awadhare, et al.
Published: (2023-01-01) -
Langerhans Cell Histiocytosis of the Cranial Base: Is Low-Dose Radiotherapy Effective?
by: Andreas Meyer, et al.
Published: (2012-01-01)